Val S. Goodfellow
14Patents
8h-index
35Co-inventors
72Inventor score
Filing activity: Jun 24, 1991 → Jun 3, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6004933A | Cysteine protease inhibitors | Emerging Cross-Sectional Technologies | 70 | Expired |
| US5811241A | Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones | Chemistry; Metallurgy | 38 | Expired |
| US8877772B2 | Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors | Chemistry; Metallurgy | 18 | Active |
| US6075120A | Bradykinin antagonist | Human Necessities | 17 | Expired |
| US5700779A | Bradykinin antagonist peptides incorporating N-substituted glycines | Human Necessities | 17 | Expired |
| US5863899A | Bradykinin antagonists | Human Necessities | 15 | Expired |
| US5610140A | Bradykinin receptor antagonists with neurokinin receptor blocking activity | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5750506A | Bradykinin antagonists with extended hydrophobic side chains | Human Necessities | 9 | Expired |
| US8846909B2 | Bicyclic heteroaryl kinase inhibitors and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9814704B2 | Substituted pyrrolo[2,3-b]pyridines as MLK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9181247B2 | Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7067509B2 | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto | Chemistry; Metallurgy | 1 | Expired |
| US5272152A | Purinyl and pyrimidinyl tetrahydrofurans | Chemistry; Metallurgy | 1 | Expired |
| US9370515B2 | Mixed lineage kinase inhibitors and method of treatments | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.